Young male patients presenting with erectile dysfunction should be screened for diabetes and prediabetes at presentation. Complications from type 2 diabetes (T2D) include kidney disease, eye disease, cardiovascular and arterial disease, and...
Young male patients presenting with erectile dysfunction should be screened for diabetes and prediabetes at presentation. Complications from type 2 diabetes (T2D) include kidney disease, eye disease, cardiovascular and arterial disease, and...
The following is a summary of “Elevated ADH5 expression suggested better prognosis in kidney renal clear cell carcinoma (KIRC) and related to immunity through single-cell and bulk RNA-sequencing,” published in the April 2024 issue of Urology by Sun et al. Despite...
1. The overall survival at 48 months was 91.2% in the pembrolizumab group vs 86.0% in the placebo group, with an HR 0.62 (significant). 2. Adverse events grade 3 or higher occurred in 18.6% of the pembrolizumab group vs 1.2% in the placebo group. Evidence Rating...
MONDAY, April 22, 2024 (HealthDay News) -- A new prostate cancer test has higher diagnostic accuracy for high-grade disease than current guideline-endorsed biomarkers, according to a study published online April 18 in JAMA Oncology.Jeffrey J. Tosoian, M.D., M.P.H.,...
MONDAY, April 22, 2024 (HealthDay News) -- Patients have lower hospital mortality and readmission rates when treated by female physicians, with a larger benefit observed for female patients, according to a study published online April 23 in the Annals of Internal...
The following is a summary of “A Novel Biopsy Scheme for Prostate Cancer: Targeted and Regional Systematic Biopsy,” published in the April 2024 issue of Urology by He et al. In this study, the researchers investigated a novel biopsy scheme for prostate cancer (PCa)...
The following is a summary of “Elevated ADH5 expression suggested better prognosis in kidney renal clear cell carcinoma (KIRC) and related to immunity through single-cell and bulk RNA-sequencing,” published in the April 2024 issue of Urology by Sun et al. Despite...
1. The overall survival at 48 months was 91.2% in the pembrolizumab group vs 86.0% in the placebo group, with an HR 0.62 (significant). 2. Adverse events grade 3 or higher occurred in 18.6% of the pembrolizumab group vs 1.2% in the placebo group. Evidence Rating...
MONDAY, April 22, 2024 (HealthDay News) -- A new prostate cancer test has higher diagnostic accuracy for high-grade disease than current guideline-endorsed biomarkers, according to a study published online April 18 in JAMA Oncology.Jeffrey J. Tosoian, M.D., M.P.H.,...
MONDAY, April 22, 2024 (HealthDay News) -- Patients have lower hospital mortality and readmission rates when treated by female physicians, with a larger benefit observed for female patients, according to a study published online April 23 in the Annals of Internal...
The following is a summary of “A Novel Biopsy Scheme for Prostate Cancer: Targeted and Regional Systematic Biopsy,” published in the April 2024 issue of Urology by He et al. In this study, the researchers investigated a novel biopsy scheme for prostate cancer (PCa)...
Even though physicians who conduct limited examinations may only be brought in for their expertise, they retain liability for malpractice or personal injury.
The right financial advisor can help physicians by answering questions including which accounts are the right fit or what insurance is appropriate.
The DIY home endeavors of Hank, a proctologist, bring amusement to Hank's cruel neighbor Zeke, an orthodontist, until a fatal twist of fate changes everything.
Health inequities pervade the healthcare system, making it crucial for physicians to reevaluate what data is being collected and who is collecting the data.
The right financial advisor can help physicians by answering questions including which accounts are the right fit or what insurance is appropriate.
Physicians face occupational hazards including blood-borne pathogens, workplace violence, and chronic pain. Safety measures are crucial for their well-being.
Insights from the leaders in medical research, trending topics in clinical medicine, and perspectives from your colleagues.
Subscribe to our free Newsletters to receive weekly emails, and even get a laugh or two from our medical cartoons.